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Background: Disease manifestations of Staphylococcus aureus are connected to the fibronectin (Fn)-binding
capacity of these Gram-positive pathogens. Fn deposition on the surface of S. aureus allows engagement of α5β1
integrins and triggers uptake by host cells. For several integrin- and actin-associated cytoplasmic proteins, including
FAK, Src, N-WASP, tensin and cortactin, a functional role during bacterial invasion has been demonstrated. As
reorganization of the actin cytoskeleton is critical for bacterial entry, we investigated whether vinculin, an essential
protein linking integrins with the actin cytoskeleton, may contribute to the integrin-mediated internalization of S.
aureus.
Results: Complementation of vinculin in vinculin -/- cells, vinculin overexpression, as well as shRNA-mediated
vinculin knock-down in different eukaryotic cell types demonstrate, that vinculin does not have a functional role
during the integrin-mediated uptake of S. aureus.
Conclusions: Our results suggest that vinculin is insignificant for the integrin-mediated uptake of S. aureus despite
the critical role of vinculin as a linker between integrins and F-actin.
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Staphylococcus aureus is often associated with nosocomial
infections, which can lead to life threatening conditions
such as acute endocarditis and bacteremia. Pathogenesis
by S. aureus involves several bacterial virulence factors
including exotoxins and adhesins [1]. Six different ad-
hesins of S. aureus (FnBPA, FnBPB, Eap, Emb, Ebh and
Aaa/Sle1) were found to bind to the extracellular matrix
(ECM) protein fibronectin [2]. In particular, bacterial cell
wall anchored fibronectin binding proteins (FnBPs) can
capture soluble fibronectin from host plasma [3]. Binding
to fibronectin is mediated by several repeats within FnBP,
which interact with the amino-terminal fibronectin type I
domains of this host glycoprotein [4]. Via an RGD motif
within one of the fibronectin type III domains, S. aureus-
associated fibronectin is able to bind with high affinity
to integrin α5β1. Accordingly, fibronectin can serve as a* Correspondence: christof.hauck@uni-konstanz.de
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reproduction in any medium, provided the ormolecular bridge connecting S. aureus with host cell re-
ceptors [5,6]. Moreover, the FnBP-fibronectin mediated
engagement of integrins triggers internalization of the
microbes by non-professional phagocytes such as epithe-
lial cells, endothelial cells, keratinocytes, and fibroblasts
[7-10]. Several investigations demonstrate the importance
of the FnBP-mediated invasion process in vivo. In a
rat model of endocarditis, S. aureus strains with reduced
fibronectin-binding capacity showed a decreased ability to
colonize damaged heart valves [11]. In addition, FnBP ex-
pression enhances the capacity of S. aureus to colonize
mammary glands and invade mammary epithelial cells in
a mouse model of mastitis [12]. Exogenous expression
of S. aureus FnBP in non-pathogenic Lactobacillus lactis
allows these bacteria to colonize damaged heart valves
and to spread to the spleen in a mouse model of endocar-
ditis [13]. Therefore, FnBP-mediated host cell contact and
cellular invasion appear to contribute to S. aureus survival
and persistence within the infected host [14]. As FnBP-
related proteins are found in other human pathogens and
as integrin-mediated host cell internalization appears cri-
tical for certain manifestations of S. aureus infections, al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ing FnBP-initiated uptake is warranted.
We and others have previously shown that fibronectin
deposition on the surface of S. aureus allows engage-
ment of α5β1 integrins and triggers the recruitment
of actin- and focal adhesion-associated proteins such as
paxillin, zyxin, tensin, cortactin, N-WASp, Arp2/3, and
FAK to the sites of bacterial attachment [5,15,16]. For
several of these proteins, including N-WASP, tensin,
FAK and cortactin, a functional role during integrin-
mediated uptake of S. aureus has been demonstrated
[15,16]. As reorganization of the actin cytoskeleton is
crucial for the internalization process [9,10,17], it is
assumed that dynamic regulation of F-actin by these
proteins contributes to bacterial uptake.
Vinculin is one of the characteristic actin-binding
proteins recruited to integrin-rich focal adhesion sites,
which mechanically links integrin cytoplasmic tails with
the actin cytoskeleton [18,19]. Vinculin has no enzyma-
tic activity and its functions are regulated by a conform-
ational switch between a closed (inactive) conformation,
mediated by an intramolecular head-tail interaction, and
an open (active) state [20]. In the open conformation,
the vinculin head and tail domains dissociate, allowing
multiple interactions with additional proteins or phos-
pholipids [21]. For example, talin, α-actinin, VASP, paxil-
lin, phosphatidylinositol-4,5-bisphosphate, and F-actin
bind to active vinculin [18]. In addition, vinculin may
promote actin filament nucleation by recruiting the
Arp2/3 complex to integrin tails [22]. Furthermore, de-
pending on the conformational state, vinculin can also
act as an F-actin barbed end capping protein [23]. A role
for vinculin during bacterial entry has been reported in
the case of Shigella flexneri. Upon contact with epithelial
cells, S. flexneri injects the IpaA protein into the host
cell cytoplasm, where IpaA directly binds to vinculin in-
ducing a dramatic rearrangement of the actin cytoskel-
eton to promote bacterial engulfment [24,25]. Vinculin
has also been observed to be recruited to S. aureus–host
cell contact sites or fibronectin-coated beads in epithe-
lial, but not in endothelial cells [15,16,22]. However, it
has not been investigated if vinculin has a functional role
during integrin-mediated internalization of S. aureus
into host cells.
In this report, we analyze the contribution of vinculin
to FnBP-mediated uptake of S. aureus in different hu-
man and murine cell types. Surprisingly, re-expression
of vinculin in vinculin-deficient fibroblasts as well as
shRNA-mediated knock-down of this protein in different
cell types do not affect bacterial uptake demonstrating
that vinculin is completely dispensable for bacterial intern-
alization via integrin α5β1. Therefore, our results suggest
that actin cytoskeleton rearrangements during integrin-
mediated endocytosis do not require vinculin functiondespite the well characterized role of vinculin as a linker
between integrins and F-actin.
Results
Enhanced cell invasion of S. aureus into vinculin knock-
out fibroblasts correlates with increased integrin α5
surface expression
Murine embryonic fibroblasts with a genetic deletion of
vinculin (vinculin -/- cells) have been generated and
been used in a previous study [26]. When grown on a
fibronectin-coated surface, vinculin -/- cells spread more
slowly and form smaller, less stable focal adhesions com-
pared to wildtype fibroblasts (vinculin WT cells) or
vinculin -/- cells re-expressing vinculin [27,28]. Total
internal reflection fluorescence (TIRF) microscopy de-
monstrates that vinculin is located in well-organized,
peripheral focal adhesions in vinculin WT cells. In vin-
culin -/- cells, no staining with the monoclonal α-vincu-
lin antibody was observed (Figure 1A). The absence of
vinculin was accompanied by a reduced size and an
altered distribution of integrin β1-containing focal ad-
hesions at the cell-substrate interface (Figure 1A). Com-
pared to vinculin -/- cells, vinculin WT cells showed
concentration of large integrin β1-containing focal adhe-
sions in the cell periphery (Figure 1A). However, the
overall amount of active integrin β1 did not differ be-
tween vinculin WT and vinculin -/- cells as detected by
a conformation-specific monoclonal antibody (Additional
file 1: Figure S1). The lack of vinculin in whole cell lysates
(WCLs) prepared from vinculin -/- cells was also con-
firmed by Western blotting (Figure 1B). Importantly, ex-
pression of several known focal adhesion proteins and
vinculin binding partners such as talin, FAK, paxillin, and
Src was not altered by the absence of vinculin (Figure 1B).
Equal loading of cell lysates for Western blotting was con-
firmed by probing for β-tubulin (Figure 1B). To test for a
functional role of vinculin in the integrin-mediated intern-
alization of bacteria, we infected these fibroblasts with
pathogenic S. aureus strain Cowan, which connects to the
host cell receptor integrin α5β1 by binding to the integrin
ligand fibronectin. As a negative control, we used non-
pathogenic S. carnosus, which lacks a fibronectin binding
adhesin and which does not invade host cells [5,15]. As
expected, host cell adhesion and invasion assays con-
firmed that S. carnosus was unable to invade fibroblasts,
whereas S. aureus attached to and invaded vinculin WT
cells (Figure 1C and D). Unexpectedly, vinculin -/- cells
showed significantly increased numbers of cell-associated
S. aureus (Figure 1C) and about 40% increase in host cell
invasion (Figure 1D). As vinculin -/- cells have undergone
several rounds of selection during their establishment
[28], compensatory mechanisms might have occurred
in the absence of vinculin. In particular, vinculin -/-
cells supported increased cell-association of S. aureus
BC
E







































































































































intβ1 intα5 intαv intβ3
Vinculin -/-
Vinculin WT
Figure 1 (See legend on next page.)
Borisova et al. BMC Cell Biology 2013, 14:2 Page 3 of 13
http://www.biomedcentral.com/1471-2121/14/2
(See figure on previous page.)
Figure 1 Increased integrin α5 expression correlates with enhanced bacterial adherence and uptake in vinculin -/- cells. (A) Vinculin WT
and vinculin -/- cells were seeded on fibronectin coated glass bottom imaging dishes, next day fixed and stained for vinculin expression using
α-human vinculin antibody (clone hVIN1). Total amounts of integrins were stained using integrin β1 antibody (clone HMβ1-1). TIRF microscopy
was used to assess the localization of vinculin and β1 integrins. Bars represent 10 μm. (B) Equal amounts of protein in the whole cell lysates
(WCL) of vinculin WT and vinculin -/- cells were separated by SDS-PAGE and processed for Western blotting using antibodies against talin, FAK,
vinculin, paxillin, Src, or β-tubulin as indicated. Representative blots are shown. (C and D) Cells were seeded on gelatine coated 24 well plates
and infected with S. aureus or S. carnosus with MOI 20 for 2 h. Total cell associated or recovered viable intracellular bacteria were determined by
bacterial cell adhesion (C) or gentamicin protection assays (D), respectively. Values are means ± SEM from 5 independent experiments done in
quadruplicate (n=20). Statistical significance of data was assessed by Mann-Whitney test. (E) Cells were stained for surface expression of β1, α5,
αv, or β3 integrins and examined by flow cytometry. Data are shown as mean fluorescence intensity (MFI) and are corrected for the background
MFI of integrin β1 -/- fibroblasts (β1 integrin staining) or corrected for the MFI of cells stained in the absence of primary antibody (α5, αv, and β3
integrin stainings). Results are shown as mean ± SEM from 3 independent experiments. (F) mRNA levels of β1, α5, αv, or β3 integrin transcripts in
vinculin WT or vinculin -/- cells were analyzed by qRT-PCR. Integrin expression was normalized to GAPDH expression and was set to 1 for vinculin
WT cells. Bars represent the mean of two independent experiments each performed in triplicate.
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host cell receptor, integrin α5β1, might be altered in these
cells. Therefore, expression of different integrin subunits
on the surface of vinculin WT and vinculin -/- cells were
investigated by flow cytometry. Whereas integrin β1 was
present in similar amounts in both cell lines, a strongly
increased surface expression of integrin α5 and a reduced
expression of the integrin αv subunit was detected in vin-
culin -/- cells (Figure 1E). Elevated amounts of integrin α5
transcripts were also detected in vinculin -/- cells by quan-
titative real-time PCR (Figure 1F). The altered integrin α5
expression in vinculin -/- cells correlated with the en-
hanced host cell binding of S. aureus. Together, these re-
sults suggested that the altered integrin expression profile
of vinculin WTcompared to vinculin -/- cells, and not the
absence of vinculin, might be responsible for the observed
differences in host cell invasion by S. aureus in these mur-
ine fibroblast lines.
Re-expression of vinculin in vinculin -/- fibroblasts does
not affect bacterial entry
To address the contribution of vinculin for host cell in-
vasion of S. aureus in an identical cellular context, we
transiently transfected vinculin -/- cells with a construct
encoding enhanced green fluorescent protein (GFP)-tag-
ged murine vinculin. As a control, an GFP encoding
vector was used. 48 h post-transfection, cells seeded on
gelatine-coated coverslips were infected with S. aureus
(MOI 50) for 2 h, fixed and, after blocking with 10% fetal
calf serum in PBS, extracellular bacteria were stained by
rabbit α-staphylococcal serum and goat α-rabbit anti-
body coupled to Cy5. After cell permeabilization, total
cell-associated bacteria were stained by applying rabbit
α-staphylococcal serum and Cy3-coupled goat α-rabbit
antibody. The double cycle antibody staining according
to this established protocol enables the discrimination
between intracellular and extracellular bacteria [29,30].
Fluorescence microscopy pictures revealed that a frac-
tion of GFP-vinculin, but not GFP, localized at focaladhesion sites in the transiently transfected vinculin -/-
cells (Figure 2A). Moreover, vinculin re-expression was
accompanied by a morphological change to a more spread
phenotype (Figure 2A). Nevertheless, both GFP as well as
GFP-vinculin expressing cells harbored intracellular bac-
teria (Figure 2A). Enumeration of cell-associated extracel-
lular or intracellular bacteria in GFP versus GFP-vinculin
transfected cells demonstrated that bacterial binding
and uptake into these cells occurred at a similar level
(Figure 2B). Thus, the transient re-expression of vinculin
in vinculin -/- cells changes the spreading of the cells,
without altering bacterial uptake, indicating that vinculin
may not contribute to the internalization of S. aureus.
Vinculin overexpression does not influence the uptake of
S. aureus in human cells
Our results that vinculin might not be necessary for
integrin-mediated uptake by murine cells were surpris-
ing, given by the fact that vinculin is recruited to the
sites of bacterial entry in human cells and has a role in
F-actin organization and focal adhesion turnover [15,28].
To analyze weather vinculin is functionally involved in
S. aureus invasion into human cells, we transiently trans-
fected 293T cells to express GFP or GFP-vinculin, respect-
ively. Western blotting with vinculin antibodies confirmed
that total vinculin levels were augmented ~10-fold follow-
ing transfection with GFP-vinculin (~145 kDa) compared
to the endogenous levels of vinculin (~120 kDa) in the
GFP transfected cells (Figure 3A). Equal loading of pro-
teins from both samples was confirmed by probing for β-
tubulin (Figure 3A). Expression levels of integrin α5 were
only slightly increased in response to vinculin overexpres-
sion (Figure 3B). Transfected cells were also seeded on
gelatine-coated wells and infected at MOI 20 for 2 h with
the FnBP-expressing S. aureus or the non-invasive S. car-
nosus. Total cell-associated bacteria as well as the num-
bers of viable intracellular bacteria were then determined.
In agreement with our previous observations, the amounts
of total cell-associated (Figure 3C), as well as the viable
AB












































Figure 2 S. aureus internalization is not affected by transient expression of vinculin in vinculin -/- cells. (A) Vinculin -/- fibroblasts were
transfected with GFP or GFP-vinculin encoding constructs. 24 h post-transfection, cells were infected with S. aureus at MOI 50 for 2 h, fixed and
stained for extracellular vs. intracellular bacteria. Representative fluorescence microscopy pictures show intracellular (arrowhead) as well as cell-
associated, extracellular (small arrow) S. aureus. (B) Cells were transfected, infected, and stained as in (A) and extra- and intracellular bacteria were
quantified. Values are presented as mean ± SEM from 2 independent experiments and based on 100 cells/sample. Data were analyzed for
statistical significance using Kruskal-Wallis test.
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pression (Figure 3D). These results demonstrate that vin-
culin overexpression does not modulate S. aureus entry
into human cells. These data also indicate that vinculin is
not a limiting factor for the integrin-mediated uptake of
these fibronectin-binding bacteria and further suggest that
the differences observed between murine vinculin WT
and vinculin -/- cells might be due to alterations in the ex-
pression pattern of integrin subunits.ShRNA-mediated vinculin silencing does not interfere
with S. aureus internalization
Though vinculin is not limiting for S. aureus uptake, en-
dogenous levels of this protein might still be needed to
support internalization. Therefore, we investigated whe-
ther shRNA-mediated knock-down of vinculin might in-
terfere with S. aureus uptake. To this end, we generated
murine fibroblasts stably transduced with recombinant






































































Figure 3 Transient vinculin overexpression in 293 cells does not interfere with bacterial uptake. (A) 293 cells were transfected with
constructs encoding GFP or GFP-vinculin. 48 h post-transfection whole cell lysates (WCLs) were prepared and analyzed for vinculin and β-tubulin
expression by immunoblotting. Representative blots are shown. (B) Cells transfected as in (A) were compared for integrin α5 surface expression
by flow cytometry. Shown is a representative histogram of cells stained with α-integrin α5 antibody and a rhodamine-coupled secondary
antibody (blue – GFP; red – GFP-vinculin) or cells stained with the secondary antibody only (grey lines). (C and D) Cells as in (A) were infected
with S. aureus and S. carnosus for 2 h (MOI 20). Total cell associated or recovered viable intracellular bacteria were determined by bacterial cell
adhesion (C) or gentamicin protection assays (D), respectively. Values are means ± SEM from 2 independent experiments done in quadruplicate,
n=8. Mann-Whitney test was applied for statistical significance testing.
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vinculin (pLKO.1 sh-mvinc). After puromycin selection,
the successful vinculin knock-down in the transduced
cell population was verified by Western blotting. Impor-
tantly, complete inhibition of mouse vinculin expression,
but unaltered expression of FAK, Src or paxillin was de-
tected (Figure 4A). Furthermore, surface levels of integrin
α5 were similar in vinculin-deficient and vinculin-expres-
sing fibroblasts (Figure 4B). Next, we were interested if
the vinculin knock-down could affect interaction of the
bacteria with host cells with regard to cell attachment and
internalization. Accordingly, pLKO.1 and pLKO.1 sh-
mvinc fibroblasts were infected with S. aureus and the
amount of total cell-associated as well as the number of
viable intracellular bacteria was determined (Figure 4C).
Though the amounts of cell-associated bacteria were
decreased in pLKO.1 sh-mvinc fibroblasts compared
to control cells, the number of intracellular bacteriain both cell populations was equal. The results from
the bacterial adhesion assay correlated with the slightly
decreased expression of integrin α5 on the surface of
vinculin knock-down cells, compared to control cells
(Figure 4B).
In a second parallel approach, we generated 293 cells
stably transduced with recombinant lentiviral particles
harboring the empty plasmid pLKO.1 or with particles
harboring plasmid pLKO.1 encoding shRNA against
human vinculin (pLKO.1 sh-hvinc). After puromycin se-
lection, pLKO.1 sh-hvinc cells showed no detectable
vinculin expression in whole cell lysates, but no alter-
ation in FAK, Src and paxillin expression (Figure 5A).
Functional assays of bacterial interaction with host cells
revealed that knock-down of vinculin in these human
cells again did not influence their ability to support
fibronectin-mediated cell attachment or internalization

















































































Figure 4 Knock-down of vinculin in wildtype fibroblasts does not affect S. aureus uptake. (A) Murine fibroblasts were transduced with
lentiviral particles harboring either pLKO.1 or pLKO.1 encoding shRNA against mouse vinculin (pLKO-1 sh-mvinc). WCL of the stably transduced
cell lines were analyzed for FAK, vinculin, paxillin, Src and β-tubulin protein expression by Western blotting. Representative blots are shown.
(B) Integrin α5 surface expression in cells from (A) was analyzed by flow cytometry. Shown is a representative histogram of cells stained with
α-integrin α5 antibodies and a rhodamine-coupled secondary antibody (blue – pLKO.1; red – pLKO.1 sh-mvinc) or cells stained with the
secondary antibody only (contr.; grey lines). (C) pLKO.1 or pLKO.1 sh-mvinc cells were seeded on gelatine coated 24 well plates. Next day, cells
were infected with S. aureus at MOI 20 for 2 h. Total cell associated or recovered viable intracellular bacteria were determined by bacterial cell
adhesion (top) or gentamicin protection assays (bottom), respectively. Values are means ± SEM from 2 independent experiments done in
quadruplicate, n=8. Mann-Whitney test was applied for statistical testing.
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is not required for S. aureus invasion in different cell ty-
pes. Although vinculin might be recruited to the site of
bacterial attachment, it has no functional role in orches-
trating the integrin-mediated internalization of staphylo-
cocci into the eukaryotic host cells.
Discussion
Since its discovery 32 years ago, vinculin has emerged as
a key structural adaptor molecule dynamically linking
integrins with the actin cytoskeleton [31]. Here we present
experimental evidence that vinculin, despite its reported
recruitment, is not required for the integrin-mediated
internalization of Staphylococcus aureus by mammaliancells. Our conclusions are based on genetic deletion of
vinculin and the complementation of the resulting vincu-
lin-deficient cells, shRNA-mediated knock-down of vincu-
lin, and overexpression of vinculin in different cell types,
as all these different treatments do not affect host cell in-
vasion by fibronectin-binding S. aureus.
Initially, we were puzzled by the finding that vinculin-
deficient murine fibroblasts showed slightly elevated asso-
ciation with and uptake of fibronectin-binding S. aureus.
However, the immortalized vinculin-deficient embryonic
fibroblasts exhibited increased expression of integrin α5
compared to wildtype fibroblasts. It is currently unclear, if
the altered expression of integrin α5 is directly caused by














































































Figure 5 Vinculin knock-down in 293 cells does not affect the uptake of S. aureus. (A) 293 cells were stably transduced with pLKO.1 or
pLKO.1 encoding shRNA against human vinculin (pLKO.1 sh-hvinc). Whole cell lysates were prepared and WCLs were analyzed by Western
blotting for vinculin, FAK, paxillin, Src, and β-tubulin expression. Representative blots are shown from 2 independent experiments. (B and C) Cells
from (A) were seeded on gelatine coated 24 well plates and infected with S. aureus at MOI 20 for 2 h. Total cell associated or recovered viable
intracellular bacteria were determined by bacterial cell adhesion (B) or gentamicin protection assays (C), respectively. Values are means ± SEM
from 4 independent experiments done in triplicate, n=12. Data were analyzed for statistical significance using Mann-Whitney test.
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teration might be due to prolonged in vitro selection and
culture of the vinculin-deficient cells. Clearly, re-expres-
sion of vinculin in the vinculin-deficient cells did not alter
integrin α5 expression and shRNA-mediated knock-down
of vinculin in different cell types did not lead to an in-
crease in integrin α5. Therefore, diminishing or increasing
vinculin levels in different cell types did neither affect in-
tegrin α5 nor integrin-mediated uptake of S. aureus sug-
gesting that changes observed in the vinculin -/- cells
might have a secondary cause.
Interestingly, vinculin is involved in cell entry of sev-
eral bacterial pathogens including Shigella flexneri and
Bartonella henselae. For example, siRNA screening has
revealed that vinculin and other integrin-associated
molecules are critical for the formation of the character-
istic invasome structure, which mediates entry of the
zoonotic pathogen B. henselae (Bh) into endothelial cells
[33].
In the case of S. flexneri, a leading cause of dysentery
worldwide, the entry into human epithelial cells is dra-
matically impaired in the absence of vinculin [25]. Upon
encounter of host cells, S. flexneri injects the IpaA pro-
tein. This effector protein contains three vinculin bind-
ing sites (VBS), which recognize the N-terminal vinculinhead domain [34,35]. Therefore, a single IpaA protein
may bind up to three vinculin molecules. Importantly,
deletion of IpaA or disruption of all three VBS in IpaA
severely impair Shigella uptake demonstrating the crit-
ical role of vinculin in this entry pathway [35]. Interest-
ingly, the VBS of IpaA are reminiscent of the vinculin
binding sites found in the carboxy-terminal rod domain
of the focal adhesion protein talin [36]. The eleven VBS
of talin also engage the vinculin head domain and help
to relief the intramolecular interactions in vinculin [18].
Accordingly, talin or IpaA binding to the vinculin head
domain result in exposure of the vinculin tail domain with
its binding sites for several proteins including F-actin,
α-actinin, or the Arp2/3 complex [35,37]. How vinculin
in its active conformation promotes Shigella entry is
not completely understood, but it has been shown that a
vinculin-binding IpaA peptide can modulate the barbed
end capping of actin filaments and thereby controls the
rate of F-actin polymerization [38]. Similarly, conform-
ational changes in vinculin induced by IpaA may also ex-
pose the binding site for the Arp2/3 complex, which is
located in a linker region between the vinculin head and
tail domain [22]. Again, this would allow Shigella to trig-
ger actin polymerization required for efficient bacterial
internalization.
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rization during bacterial entry comes from the study of
Helicobacter pylori, an extracellular pathogen, which can
engage integrins without being internalized [39]. H. pylori
translocates the type IV secretion system effector protein
CagA into gastric epithelial cells [40]. Bacterial CagA is
initially tyrosine phosphorylated and subsequently inhibits
the catalytic activity of Src family protein tyrosine kinases
[41,42]. The lack of Src activity results in severely reduced
phosphorylation of vinculin on residues Y100 and Y1065,
disrupting interactions between vinculin and the Arp2/3
complex, and blocking actin cytoskeleton rearrangements
in epithelial cells [43]. Together these results suggest that
vinculin is a central host factor targeted by several bacter-
ial effector proteins to orchestrate actin cytoskeleton rear-
rangements to the advantage of the pathogens.
As actin cytoskeleton dynamics are also essential for
S. aureus host cell entry, yet vinculin does not seem to
participate functionally in this process, regulation of
actin dynamics might be achieved in a different manner
during uptake of fibronectin-binding staphylococci.
Previous results indicate that fibronectin-dependent,
integrin-mediated internalization of S. aureus into host
cells requires the integrin-associated tyrosine kinases Src
and FAK [10,15,17]. One downstream substrate of the ac-
tive FAK/Src complex is cortactin [44,45]. Indeed, cortac-
tin is strongly tyrosine phosphorylated upon contact of
fibronectin-binding S. aureus with host cells and deple-
tion of cortactin reduces S. aureus invasion [15]. Recent
studies have demonstrated cortactin directly associates
with FAK via SH3 domain-mediated binding to proline-
rich sequences in FAK [45,46]. As cortactin is also able
to organize the F-actin cytoskeleton and to stimulate the
actin polymerizing Arp2/3 complex [47,48], recruitment
and tyrosine phosphorylation of cortactin might direct
the cytoskeletal rearrangements during S. aureus intern-
alization, superseding vinculin function downstream of
integrin engagement.
Taken together, our investigations come to the sur-
prising conclusion that vinculin is not required for the
integrin-mediated uptake of S. aureus into host cells.
Despite the documented role of vinculin in dynamically
linking integrins with the actin cytoskeleton, our results
suggest that other cellular factors, such as the FAK-Src-
cortactin signaling axis, are critical for triggering actin
remodeling and bacterial entry during integrin endocyto-
sis. It also appears likely that uptake of other pathogens,
which engage integrins for host cell invasion, might be
also independent of vinculin function.
Methods
Cell culture and transfection
Human embryonic kidney 293T cell line (293 cells,
ACC-635, German Collection of Microorganisms and CellCultures, DSMZ, Braunschweig, Germany) was grown in
DMEM high glucose (PAA, Pasching, Austria) supple-
mented with 10% calf serum (CS). Mouse embryonic fib-
roblasts were grown on gelatine-coated cell culture dishes
in DMEM high glucose supplemented with 10% fetal calf
serum (FCS; Biochrom, Berlin, Germany), non-essential
amino acids and sodium pyruvate. Vinculin wildtype and
vinculin -/- cells were generated from mice kindly pro-
vided by E.D. Adamson (Burnham Institute, La Jolla, CA)
[49]. The fibroblasts were newly derived from mouse
embryos and immortalized with SV40 largeT antigen
as described [26]. All cell cultures were incubated at
37°C/5% CO2 and subcultured every 2 to 3 days. Cells
were used between passage 2 and 30, counted and assayed
for viability with a Casy Cell Counter (Innovatis, Bielefeld,
Germany).
Transfection of 293 cells with expression vectors for
GFP (Clontech) or GFP-mouse vinculin [50] was accom-
plished by standard calcium phosphate co-precipitation
using 3.5 μg of plasmid DNA for each 10 cm culture
dish as previously described [51]. Fibroblasts were trans-
fected using Lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instruc-
tions. Cells were employed in infection experiments 24
to 48 h after transfection.
Bacteria
Staphylococcus aureus Cowan and non-pathogenic S.
carnosus TM300 have been described before [15]. Bac-
teria were cultured at 37°C and grown on Tryptic Soy-
bean Broth medium (TSB; BD Biosciences, Heidelberg,
Germany). Prior to the experiment bacteria were grown
to reach a mid-logarithmic growth phase, washed once
with PBS and used for infection at multiplicity of infec-
tion (MOI) 20 for gentamicin protection assays and
MOI 50 for microscopic evaluation of extra- and intra-
cellular bacteria.
shRNA construction and lentiviral production
Recombinant lentiviral particles were generated using
the plasmids pLKO.1, pMD2.G, and psPAX2 provided by
Addgene (www.addgene.org) and maintained in E. coli
STBL4 (Invitrogen, Carlsbad, CA). Using the algorithm
AAGN18TT (available online at http://jura.wi.mit.edu/
bioc/siRNAext/) sequences that could silence expression
of human or mouse vinculin were identified. Accord-
ing to these predictions, complementary primers were





or targeting murine vinculin mRNA: mVinculin-shRNA-
sense 50-ccggaaATCTGGCTGGTACATACACctcgagGTG




gos were annealed and cloned into the AgeI and EcoRI
sites of pLKO.1 generating pLKO.1-sh-hvinc and pLKO.1-
sh-mvinc constructs, respectively. The correct insertion of
the shRNA cassette was verified by sequencing.
For lentiviral production, 2 × 106 293 cells were transi-
ently transfected with 14 μg of the respective pLKO.1
vector together with 10 μg of packaging plasmid psPAX2
and 7 μg of envelope-coding plasmid pMD2.G. 48 h
later, the virus-containing cell culture supernatant was
collected, centrifuged at 2000 rpm at 4°C for 7 min and
filtered through a 0.45 μm pore-size filter. 6 ml of the
cleared viral supernatant was used to transduce 293 cells
or fibroblasts in 10 cm culture dishes. After 24 h, puro-
mycin (0.45 μg/ml for 293 cells and 2.5 μg/ml for fibro-
blasts) was added and the puromycin-resistant stable
cell population was used in experiments after 7 days of
selection.
Quantification of surface integrin expression by flow
cytometry
Integrin α5 (clone 5H10-27(MFR5)) and integrin αv (clone
RMV-7) antibodies were purchased from BD Biosciences.
Integrin β1 (clone CBL1333F) was obtained from Cymbus
Biotechnology (London, UK) and integrin β3 antibody
(clone 2C9.G3) from eBioscience (San Diego, CA). Secon-
dary antibodies (biotin-SP-conjugated goat α-mouse IgG,
biotin-SP-conjugated goat α-rat IgG), streptavidin–FITC
and streptavidin-rhodamine (TRITC) were purchased
from Jackson ImmunoResearch (West Grove, PA). For
quantification of surface integrin expression, suspended
fibroblasts were incubated in suspension medium (DMEM
containing 0.25% BSA) for 40 min at 37°C. Then, 2 × 105
cells were incubated with appropriate primary antibodies
(diluted 1:500) in FACS buffer (5% heat-inactivated FCS,
1% sodium azide in PBS) for 1 h at 4°C. After washing,
secondary antibodies were applied for 1h at 4°C, and after
washing, samples were analyzed by flow cytometry (LSRII,
BD Biosciences).
qRT-PCR evaluation of integrin mRNA levels
Total RNA was isolated from vinculin wild type and vin-
culin -/- cells cells using RNeasy Mini Kit (Qiagen, Hil-
den, Germany). Reverse transcription was performed on
1 μg total RNA. Quantitative real-time PCR was con-
ducted with the sensiMixPlus SYBR Kit (Quantace,
Germany) with the following cycle conditions: 95°C for
10 min followed by 40 cycles at 95°C for 10 s, 60°C for
20 s, and 72°C for 20 s. Relative expression of αv-, α5-,
β1-, β3-integrins was normalized using glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) according to the
method by Livak and Schmittgen [52]. The primers usedwere: mouse αv-integrin (forward: 50-TTGGG GACGA
CAACC CTCTG ACAC-30; reverse: 50-TGCGG CGGGA
TAGAA ACGAT GAG-30); mouse α5-integrin (forward:
50- CACTT GGCTT CAGGG CATTT C-30; reverse: 50-
CAACT ACACC CCCAA CTCAC AGG-30); mouse β1-
integrin (forward: 50- TCTCA CCAAA GTAGA AAGCA
GGGA-30; reverse: 50- ACGAT AGCTT CATTG TTGCC
ATTC-30); mouse β3-integrin (forward: 50- GCTTT GG
GGC CTTCG TGGAC AA-30; reverse: 50- CATGG GC
AAG CAGGC ATTCT TCAT-30); and mouse GAPDH
(forward: 50- TGCAC CACCA ACTGCT TAG-30; reverse:
50- GGATG CAGGG ATGAT GTTC-30).
Gentamicin protection assay
Briefly, 2 × 105 293 cells or 1 × 105 fibroblasts were see-
ded on gelatine coated (0.1% in PBS) 24 well plates. Cells
were infected with 20 bacteria per cell (MOI 20) for 2 h.
To evaluate the number of intracellular bacteria, the
medium was replaced with DMEM containing 50 μg/ml
gentamicin. After incubation for 1 h at 37°C, intracellu-
lar bacteria were released by treatment with 0.5%
saponin in PBS for 10 min at 37°C. Samples were diluted
in PBS and plated on TSB agar plates for determination
of the recovered colony forming units (cfu). Total cell
associated bacteria were determined in separate samples
by omitting the incubation with gentamicin and washed
once (293) or twice (fibroblasts) with PBS before lysis by
0.5% saponin in PBS.
Fluorescence staining of vinculin and total internal
reflection fluorescence (TIRF) microscopy
3 × 104 vinculin WT and vinculin -/- cells were plated
on 4 μg/ml fibronectin coated glass bottom imaging di-
shes. Next day, cells were washed once with PBS+/+ (PBS
supplemented with Ca2+ and Mg2+) and fixed with 4%
paraformaldehyde for 20 min. For vinculin staining, fi-
xed samples were washed twice and permeabilized for
10 min in Triton X100 solution (0.5% in PBS). After
three washing steps unspecific binding sites were satu-
rated by incubating the samples with blocking buffer
(10% heat inactivated FCS in PBS+/+) for 10 min. Then,
samples were incubated with 1:500 diluted monoclonal
mouse α-human vinculin antibody (clone hVIN1; Sigma-
Aldrich, Steinheim, Germany) in blocking buffer for
30 min. Samples were washed three times, blocked for
10 min and incubated with biotin-SP-conjugated goat
α-mouse IgG antibody (1:500) for 30 min in blocking
buffer. Samples were washed again and incubated for
30 min with streptavidin–FITC (1:500) in the dark. All
fluorescence staining steps were performed at room tem-
perature. In addition, samples were co-stained for integrin
β1 (clone HMβ1-1; BioLegend, San Diego, CA) together
with rhodamine conjugated goat-α-armenian hamster IgG
antibody (Jackson ImmunoResearch) or for active integrin
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integrin β1) together with rhodamine conjugated goat-α-
rat IgG (Jackson ImmunoResearch). Antibodies were di-
luted 1:300 and samples were analyzed by Total Internal
Reflection Fluorescence (TIRF) microscopy. Images were
acquired using a Leica AF6000LX TIRF system (Leica,
Mannheim, Germany) equipped with 100x/1.46 NA Oil
HCX PL Apo objective and EMCCD camera (Casca-
deII:512). Images were digitally processed using ImageJ.
Cell lysis and western blotting
Cell lysis and Western blotting were performed as descri-
bed [51] with some modifications. Briefly, protein concen-
tration was assessed using Pierce bicinchoninic assay kit
(Thermo Fisher Scientific, Waltham, MA). Equal amounts
of proteins were loaded on SDS-PAGE gels. Antibodies
against FAK (clone 77) and paxillin (clone 177) were from
BD Biosciences, against talin (clone H-300) from Santa
Cruz (Santa Cruz, CA) and against vinculin (clone hVIN1)
was from Sigma-Aldrich. Antibody against β-tubulin (E-7)
and Src were purified from hybridoma cell supernatants.
Goat anti-mouse IgG coupled to HRP was purchased
from Jackson ImmunoResearch.
Staining of extra- and intracellular bacteria and
fluorescence microscopy evaluation
3 × 104 vinculin -/- cells were seeded on gelatine coated
acid washed glass cover slips in 24 well plates. Next day,
cells were transfected with GFP or GFP-mouse vinculin
using Lipofectamine 2000. 24 h after transfection, cell
culture medium was exchanged and cells were infected
with Staphylococcus aureus (MOI 50) for 2 h, washed
twice with PBS+/+ and fixed with 4% paraformaldehyde
in PBS for 20 min at RT, incubated in blocking buf-
fer for 10 min. Extracellular bacteria were stained using
rabbit polyclonal α-staphylococcal serum diluted in block-
ing buffer (45 min at RT). Afterwards, samples were
washed three times and incubated with goat α-rabbit IgG-
Cy5 (Jackson Immunoresearch) in the dark for 30 min.
After three washing steps, cells were permeabilized using
0.5% Triton/PBS for 10 min, washed three times and
blocked additionally for 10 min. Then, after incubation
with rabbit polyclonal α-staphylococcal serum, samples
were washed three times and incubated with goat α-rabbit
IgG coupled to Cy3 in the dark for 30 min. Finally, after
three washes with PBS, the coverslips were mounted in
embedding medium (DaKo, Glostrup, Denmark) on glass
slides and sealed with nail polish. Images were acquired
with a Leica AF6000LX fluorescence microscope and pro-
cessed with ImageJ.
Statistics
Infection and flow cytometry experiments were per-
formed two to five times, and data were presented asmean ± SEM. Differences in adherence and internalization
of staphylococci were analyzed by Mann-Whitney test or
for more than 2 groups of analysis by Kruskal-Wallis test.
In all analyses, p value <0.05 was considered statistically
significant.
Conclusions
This study demonstrates that the focal adhesion protein
vinculin does not contribute to the integrin-mediated
uptake of fibronectin-binding S. aureus. This result is
unexpected given the critical role of vinculin as a linker
between integrins and F-actin.
Additional file
Additional file 1: Figure S1. Similar distribution of active β1 integrins in
vinculin -/- and vinculin WT cells. Vinculin WT and vinculin -/- cells were
seeded on Fn coated glass bottom imaging dishes, next day fixed and
stained for vinculin using mouse α-human vinculin (hVIN1) antibody,
combined with biotin-SP-conjugated goat α-mouse IgG and streptavidin-
FITC. In addition, integrin β1 in the ligand-bound, active conformation
was detected by rat monoclonal integrin β1 antibody (clone 9EG7)
together with rhodamine red conjugated goat-α-rat IgG antibody. TIRF
microscopy was used to assess the distribution of vinculin and active β1
integrins. Bars represent 10 μm.
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